1. Home
  2. YMAB vs MQT Comparison

YMAB vs MQT Comparison

Compare YMAB & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • MQT
  • Stock Information
  • Founded
  • YMAB 2015
  • MQT 1992
  • Country
  • YMAB United States
  • MQT United States
  • Employees
  • YMAB N/A
  • MQT N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • MQT Investment Bankers/Brokers/Service
  • Sector
  • YMAB Health Care
  • MQT Finance
  • Exchange
  • YMAB Nasdaq
  • MQT Nasdaq
  • Market Cap
  • YMAB 270.5M
  • MQT 225.3M
  • IPO Year
  • YMAB 2018
  • MQT N/A
  • Fundamental
  • Price
  • YMAB $4.43
  • MQT $10.01
  • Analyst Decision
  • YMAB Buy
  • MQT
  • Analyst Count
  • YMAB 11
  • MQT 0
  • Target Price
  • YMAB $18.73
  • MQT N/A
  • AVG Volume (30 Days)
  • YMAB 328.7K
  • MQT 52.5K
  • Earning Date
  • YMAB 03-04-2025
  • MQT 01-01-0001
  • Dividend Yield
  • YMAB N/A
  • MQT 4.60%
  • EPS Growth
  • YMAB N/A
  • MQT N/A
  • EPS
  • YMAB N/A
  • MQT N/A
  • Revenue
  • YMAB $87,685,000.00
  • MQT N/A
  • Revenue This Year
  • YMAB $20.07
  • MQT N/A
  • Revenue Next Year
  • YMAB $8.76
  • MQT N/A
  • P/E Ratio
  • YMAB N/A
  • MQT N/A
  • Revenue Growth
  • YMAB 3.38
  • MQT N/A
  • 52 Week Low
  • YMAB $4.25
  • MQT $8.59
  • 52 Week High
  • YMAB $17.78
  • MQT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 34.59
  • MQT 41.44
  • Support Level
  • YMAB $4.65
  • MQT $9.98
  • Resistance Level
  • YMAB $5.25
  • MQT $10.31
  • Average True Range (ATR)
  • YMAB 0.30
  • MQT 0.10
  • MACD
  • YMAB 0.03
  • MQT -0.01
  • Stochastic Oscillator
  • YMAB 6.32
  • MQT 16.67

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About MQT Blackrock MuniYield Quality Fund II Inc.

BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.

Share on Social Networks: